409
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation

Pages 453-459 | Received 19 Dec 2014, Accepted 24 Feb 2015, Published online: 27 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Pernille B. Elming, Brita S. Sørensen, Harald Spejlborg, Jens Overgaard & Michael R. Horsman. (2021) Does the combination of hyperthermia with low LET (linear energy transfer) radiation induce anti-tumor effects equivalent to those seen with high LET radiation alone?. International Journal of Hyperthermia 38:1, pages 105-110.
Read now
Hans Crezee, Caspar M. van Leeuwen, Arlene L. Oei, Lukas J.A. Stalpers, Arjan Bel, Nicolaas A. Franken & H. Petra Kok. (2016) Thermoradiotherapy planning: Integration in routine clinical practice. International Journal of Hyperthermia 32:1, pages 41-49.
Read now
Michael R. Horsman. (2016) Realistic biological approaches for improving thermoradiotherapy. International Journal of Hyperthermia 32:1, pages 14-22.
Read now

Articles from other publishers (6)

Xiangping Deng, Yiyuan Pi, Zhongli Li, Runde Xiong, Juan Liu, Jingduo Zhao, Zhizhong Xie, Xiaoyong Lei & Guotao Tang. (2020) FB-15 inhibits MGC-803 cells growth by regulating energy metabolism. Chemico-Biological Interactions 327, pages 109186.
Crossref
Michael R. Horsman, Thomas R. Wittenborn, Patricia S. Nielsen & Pernille B. Elming. (2020) Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents. International Journal of Molecular Sciences 21:13, pages 4778.
Crossref
Letizia Procaccio, Vera Damuzzo, Francesca Di Sarra, Alberto Russi, Federica Todino, Vincenzo Dadduzio, Francesca Bergamo, Alessandra Anna Prete, Sara Lonardi, Hans Prenen, Angelo Claudio Palozzo & Fotios Loupakis. (2019) Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies. Drug Safety 42:2, pages 159-179.
Crossref
Pernille Elming, Brita Sørensen, Arlene Oei, Nicolaas Franken, Johannes Crezee, Jens Overgaard & Michael Horsman. (2019) Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia. Cancers 11:1, pages 60.
Crossref
Xiangping Deng, Zhongli Li, Runde Xiong, Juan Liu, Renbo Liu, Junmei Peng, Yanming Chen, Xiaoyong Lei, Xuan Cao, Xing Zheng, Zhizhong Xie & Guotao Tang. (2019) FS-7 inhibits MGC-803 cells growth in vitro and in vivo via down-regulating glycolysis. Biomedicine & Pharmacotherapy 109, pages 1659-1669.
Crossref
О. Курпешев, O. Kurpeshev, J. van der Zee J. van der Zee & J. van der Zee J. van der Zee. (2018) Experimental Basis for the Use of Hyperthermia in Oncology. Medical Radiology and radiation safety 63:1, pages 57-77.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.